Best Practice for Late Stage Funding - Kameel Farag, Hari Pujar, Randy Berholtz
Manage episode 355055039 series 2807843
Our expert panel of C-level executives and board members reveal their tips tricks for successful late stage funding rounds. Great insight from:
Hari Pujar - Operating Partner at Flagship Therapeutics and COO at Tessera Therapeutics
Randy Berholtz - Chair and Chief Executive Officer Chair and Chief Executive Officer - Rancho Santa Fe Bio, Inc.
Kameel Farag - CFO Aspen NeuroScience
Hosted by Jared Green and Alex Cooke from Phase 3 Search
www.ph3.bio
8 에피소드